Related disorders to PUD Flashcards

1
Q

Severe peptic ulcer diathesis secondary to gastric acid hypersecretion due to unregulated gastrin release from a non-β cell often well-differentiated neuroendocrine tumor (gastrinoma)

A

ZES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

driving force responsible for the clinical manifestations in ZES

A

Hypergastrinemia originating from an autonomous neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Over 80% of gastrinomas are found within the hypothetical gastrinoma triangle…

A

confluence of the
* cystic and common bile ducts superiorly
* junction of the second and third portions of the duodenum inferiorly
* and junction of the neck and body of the pancreas medially

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the most common clinical manifestation in ZES
vs the 2nd most common

A
  1. Peptic ulcer
  2. Diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Duodenal tumors constitute the most common nonpancreatic lesion in ZES. True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gastrinomas can develop in the presence of tihs endocrine syndrome

A

MEN 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The first step in the evaluation of a patient suspected of having ZES is

A

to obtain a fasting gastrin level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When to exclude ZES in the diffentials using fasting gastrin

A

A normal fasting gastrin, on two separate occasions, especially if the patient is on a PPI, virtually excludes this diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The effect of the PPI on gastrin levels and acid secretion will linger several days after stopping the PPI; therefore, it should be stopped for a minimum of ____days before testing.

A

seven

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

histamine H2 antagonist, such as famotidine needs to be stopped ____ days before testing for gastrin level

A

1 day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The next step at times needed for establishing a biochemical diagnosis of gastrinoma is to assess WHAT

A

acid secretion

first step is to assess gastrin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a pH ____ is suggestive of a gastrinoma,

A

less than 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A BAO ________meq/h in the presence of hypergastrinemia is considered pathognomonic of ZES,

A

A BAO more than 15 meq/h in the presence of hypergastrinemia is considered pathognomonic of ZES,

16
Q

most sensitive and specific gastrin provocative test for the diagnosis of gastrinoma is __________

A

the secretin study

17
Q

PPI-induced hypochlorhydria or achlorhydria may lead to a false-positive secretin test

A

Why is PPI stopped 1 week prior to secretin test

18
Q

Once a biochemical diagnosis has been confirmed in ZES, the patient should first undergo …. to exclude metastatic disease

A
  • an abdominal computed tomography (CT) scan
  • magnetic resonance imaging (MRI)
  • OctreoScan/PET-CT with68 Ga-DOTATATE (depending on availability
19
Q

treatment of choice for ZES

20
Q

Favorable prognostic indicators in ZES

A
  • primary duodenal wall tumors
  • isolated lymph node tumor
  • the presence of MEN 1,
  • and undetectable tumor upon surgical exploration
21
Q

The most common causes of acute gastritis are

A

infectious ( H pylori)

22
Chronic atrophic gastritis Type A vs Type B
Chronic atrophic gastritis A. Type A: Autoimmune, body-predominant B. Type B: H. pylori–related, antral-predominant
23
stages of chronic gastritis (3)
24
denotes the conversion of gastric glands to a small intestinal phenotype with small-bowel mucosal glands containing goblet cells.
intestinal metaplasia
25
which is less common... Type A or Type B gastritis
Type A
26
Traditionally, this form of gastritis has been associated with pernicious anemia
Type A
27
Treatment for pernicious anemia
long term parenteral vitamin B supplementation
28
________ is characterized histologically by intense infiltration of the surface epithelium with lymphocytes. The infiltrative process is primarily in the body of the stomach and consists of mature T cells and plasmacytes.
Lymphocytic gastritis
29
A subgroup of patients with lymphocytic gastritis have thickened folds noted on endoscopy. These folds are often capped by small nodules that contain a central depression or erosion; this form of the disease is called ____
varioliform gastritis
30
eosinophilic gastritis, what layers of the stomach are involved
any layer of the stomach (mucosa, muscularis propria, and serosa)
31
Term for a mucosal lesion of unknown etiology that has a pseudotumoral endoscopic appearance.
Russell body gastritis (RBG)
32
Histologically, it is defined by the presence of numerous plasma cells containing Russell bodies (RBs) that express kappa and lambda light chains.
Russell body gastritis (RBG)
33
a very rare gastropathy characterized by large, tortuous mucosal folds.
Ménétrier’s disease (MD)
34
mucosal folds in MD are often most prominent in the what part of the stomach
body and fundus, sparing the antrum.
35
Histologically, massive foveolar hyperplasia (hyperplasia of surface and glandular mucous cells) and a marked reduction in oxyntic glands and parietal cells and chief cells are noted.
Menetrier's disease
36
etiology of Menetrier's disease in children vs adults
The etiology of this unusual clinical picture in children is often CMV, but the etiology in adults is unknown.
37
How to diagnose Menetrier's disease
Endoscopy with deep mucosal biopsy, preferably full thickness with a snare technique
37
Drug that can cause near complete histologic remission in Menetrier's disease
Cetuximab
38
First line treatment for Menetrier's disease
Cetuximab ## Footnote `
39
40